Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch | PRODUCT CODE: 1595556

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1595556

Preclinical Medical Device Testing Services Market by Service (Antimicrobial Activity Testing, Bioburden Determination, Biocompatibility Test), Phase (Antimicrobial Wound Dressings, Medical Coatings) - Global Forecast 2025-2030

PUBLISHED:
PAGES: 198 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF, Excel & 1 Year Online Access (Single User License)
USD 3939
PDF, Excel & 1 Year Online Access (Enterprise User License)
USD 6969

Add to Cart

The Preclinical Medical Device Testing Services Market was valued at USD 6.54 billion in 2023, expected to reach USD 7.34 billion in 2024, and is projected to grow at a CAGR of 12.66%, to USD 15.07 billion by 2030.

Preclinical medical device testing services are critical in ensuring the safety and efficacy of medical devices before they reach clinical trials. This involves assessments of biocompatibility, functionality, and performance through various methods such as in vitro and in vivo studies. The necessity of these services stems from the demand for stringent regulatory compliance and the need to mitigate potential risks associated with medical device failures. Applications of preclinical testing are wide-ranging, covering device categories like implantable devices, diagnostic equipment, and surgical instruments. The end-use scope primarily includes medical device manufacturers, research institutions, and regulatory bodies keen on device validation and safety assurance. Market growth is primarily driven by increasing R&D investments in innovative medical technologies, heightened regulatory scrutiny, and the rising prevalence of chronic diseases that necessitate advanced medical solutions. Moreover, advances in materials science and biomarker technologies present lucrative opportunities for growth. However, market expansion faces challenges such as high costs associated with comprehensive testing processes and potential delays due to regulatory approvals, which can deter smaller companies with budget constraints. Additionally, evolving regulations pose a compliance challenge for market players. Opportunities abound in the development of cost-effective testing methodologies and the integration of AI and machine learning for predictive analytics and efficient test designs. Moreover, focusing on specific segments like wearable medical devices can provide substantial growth potential. To capitalize on these opportunities, companies should prioritize investing in cutting-edge technologies and foster collaborations with academic and research institutions to enhance testing capabilities. Despite the competitive landscape, continuous innovation and adaptation to technological advancements will likely drive market success, positioning companies to effectively navigate the complexities of regulatory environments while meeting growing demands for medical device testing.

KEY MARKET STATISTICS
Base Year [2023] USD 6.54 billion
Estimated Year [2024] USD 7.34 billion
Forecast Year [2030] USD 15.07 billion
CAGR (%) 12.66%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Preclinical Medical Device Testing Services Market

The Preclinical Medical Device Testing Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing need for validation and verification of medical devices
    • Favorable government initiatives and investments to develop healthcare infrastructure
    • Rapid demand for outsourcing medical device testing services
  • Market Restraints
    • Limited infrastructural setup and complex services
  • Market Opportunities
    • Development in IoT and AI in various medical devices
    • Technological advancements and innovations in medical device testing services
  • Market Challenges
    • Concerns regarding standardized overseas qualification tests

Porter's Five Forces: A Strategic Tool for Navigating the Preclinical Medical Device Testing Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Preclinical Medical Device Testing Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Preclinical Medical Device Testing Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Preclinical Medical Device Testing Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Preclinical Medical Device Testing Services Market

A detailed market share analysis in the Preclinical Medical Device Testing Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Preclinical Medical Device Testing Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Preclinical Medical Device Testing Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Preclinical Medical Device Testing Services Market

A strategic analysis of the Preclinical Medical Device Testing Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Preclinical Medical Device Testing Services Market, highlighting leading vendors and their innovative profiles. These include Bureau Veritas S.A., Charles River Laboratories, Inc., Eurofins Scientific (Ireland) Limited, Intertek Group PLC, Medistri SA, Nelson Labs NV, PaxeraHealth LLC, Pharmacology Discovery Services Taiwan, Ltd., SGS Societe Generale de Surveillance SA, Sipra Labs Limited, Sterigenics International LLC, TUV Rheinland AG, UL LLC, Viroclinics Biosciences, and WuXi AppTec Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Preclinical Medical Device Testing Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Service, market is studied across Antimicrobial Activity Testing, Bioburden Determination, Biocompatibility Test, Chemistry Test, Microbiology Test & Sterility, Pyrogen & Endotoxin Testing, and Sterility Test & Validation.
  • Based on Phase, market is studied across Antimicrobial Wound Dressings and Medical Coatings.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-3A2E844FD678

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing need for validation and verification of medical devices
      • 5.1.1.2. Favorable government initiatives and investments to develop healthcare infrastructure
      • 5.1.1.3. Rapid demand for outsourcing medical device testing services
    • 5.1.2. Restraints
      • 5.1.2.1. Limited infrastructural setup and complex services
    • 5.1.3. Opportunities
      • 5.1.3.1. Development in IoT and AI in various medical devices
      • 5.1.3.2. Technological advancements and innovations in medical device testing services
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns regarding standardized overseas qualification tests
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Preclinical Medical Device Testing Services Market, by Service

  • 6.1. Introduction
  • 6.2. Antimicrobial Activity Testing
  • 6.3. Bioburden Determination
  • 6.4. Biocompatibility Test
  • 6.5. Chemistry Test
  • 6.6. Microbiology Test & Sterility
  • 6.7. Pyrogen & Endotoxin Testing
  • 6.8. Sterility Test & Validation

7. Preclinical Medical Device Testing Services Market, by Phase

  • 7.1. Introduction
  • 7.2. Antimicrobial Wound Dressings
  • 7.3. Medical Coatings

8. Americas Preclinical Medical Device Testing Services Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Preclinical Medical Device Testing Services Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Preclinical Medical Device Testing Services Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Bureau Veritas S.A.
  • 2. Charles River Laboratories, Inc.
  • 3. Eurofins Scientific (Ireland) Limited
  • 4. Intertek Group PLC
  • 5. Medistri SA
  • 6. Nelson Labs NV
  • 7. PaxeraHealth LLC
  • 8. Pharmacology Discovery Services Taiwan, Ltd.
  • 9. SGS Societe Generale de Surveillance SA
  • 10. Sipra Labs Limited
  • 11. Sterigenics International LLC
  • 12. TUV Rheinland AG
  • 13. UL LLC
  • 14. Viroclinics Biosciences
  • 15. WuXi AppTec Co., Ltd.
Product Code: MRR-3A2E844FD678

LIST OF FIGURES

  • FIGURE 1. PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY ANTIMICROBIAL ACTIVITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY BIOBURDEN DETERMINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY BIOCOMPATIBILITY TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY CHEMISTRY TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY MICROBIOLOGY TEST & STERILITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PYROGEN & ENDOTOXIN TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY STERILITY TEST & VALIDATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY ANTIMICROBIAL WOUND DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY MEDICAL COATINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 104. PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 105. PRECLINICAL MEDICAL DEVICE TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!